August 2013 FDA Recall Drug by Central Shared Services Dba Parallon
D-1062-2014 - CGMP Deviation
This Class II drug recall was voluntarily initiated by Central Shared Services Dba Parallon on August 23, 2013 for the product Drug. The FDA reported the reason for recall as cgmp deviation. The product was distributed in GA, KY, TN and the recall is currently terminated.
Recall Number: D-1062-2014
CGMP Deviation: Discoloration; Product fails specification for appearance/color. A complaint was received regarding an abnormal appearance of children's ibuprofen suspension.
08-23-2013
02-12-2014
3764 cups
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Central Shared Services dba Parallon
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
E-Mail
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
GA, KY, TN
02-04-2014
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
CHILDREN'S IBUPROFEN, ORAL SUSPENSION, 200 mg/10mL cup BERRY FLAVOR, ALCOHOL FREE, MFG: ACTAVIS, PGK BY SAFECOR Columbus, OH
Batch or Lot Expiration Information
Lot# 600709, Use by: 04/14; 598148, Use by 04/14; 567904, Use by 01/14; 606466, Use by 05/14